IDEXX rides on strong diagnostics growth and software momentum, but FX pressure and weak solvency cloud its outlook - should ...
Zacks Investment Research on MSN
IDEXX Laboratories stock up 39.4% in a year: What's driving it?
Shares of IDEXX Laboratories IDXX have rallied 39.1% over the past 12 months, showing impressive momentum. The stock has outpaced its industry, which rose 2.3%, as well as the S&P 500 Composite’s 29.6 ...
Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ...
In the latest quarter, 4 analysts provided ratings for IDEXX Laboratories (NASDAQ:IDXX), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 first quarter financial results for Tuesday, May 5, 2026, before the market ...
IDEXX Laboratories (NASDAQ:IDXX) will release its quarterly earnings report on Monday, 2026-02-02. Here's a brief overview for investors ahead of the announcement. Analysts anticipate IDEXX ...
Upgraded IDEXX to 'Buy' with a $450 price target due to oncology business expansion and share repurchase program. IDEXX's oncology market entry with Cancer Dx panel in March 2025 could drive ...
Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
How much a stock's price changes over time is important for most investors, since price performance can both impact your investment portfolio and help you compare investment results across sectors and ...
IDEXX Laboratories, Inc. (IDXX)’s share price is up by 2.6% over the past month. Over the past five years, IDEXX has been up 50% in the last five years, which is less than the market return. The last ...
Shares of IDEXX Laboratories Inc. IDXX shed 1.43% to $570.21 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.37% to 6,556.37 ...
While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results